Skip to main content
Top

International Cancer Conference Journal

Issue 2/2019

Content (9 Articles)

Cytostatic Therapy Review article

Systematic review of case reports of Japanese esophageal neuroendocrine cell carcinoma in the Japanese literature

Yoshinori Kikuchi, Hideaki Shimada, Kazuhisa Yamaguchi, Yoshinori Igarashi

Spontaneous regression of a carcinoid tumor that required resection owing to its reappearance and subsequent enlargement after 2 years: a case report

Tsuyoshi Uchida, Hirochika Matsubara, Aya Sugimura, Hiroyasu Matsuoka, Tomofumi Ichihara, Hiroyuki Nakajima

Laparotomy Case report

Primary retroperitoneal squamous cell carcinoma: a case report with review of the literature

Yu Matsuzaka, Ken Yamaguchi, Koki Moriyoshi, Yumi Takao, Kenji Takakura, Ikuo Konishi

Lymphoma Case report

Mass-forming mucosa-associated lymphoid tissue lymphoma of the cecum treated by laparoscopy-assisted bowel resection

Yuki Nakamura, Kenji Matsuda, Shozo Yokoyama, Koichi Tamura, Yasuyuki Mitani, Hiromitsu Iwamoto, Yuki Mizumoto, Daisuke Murakami, Masakazu Fujimoto, Hiroki Yamaue

Acute arteritis after G-CSF administration

Yasuyuki Kinjo, Tomoko Kurita, Taeko Ueda, Seiji Kagami, Yusuke Matsuura, Kiyoshi Yoshino

NSCLC Case report

Erlotinib and bevacizumab combination therapy for afatinib-refractory leptomeningeal carcinomatosis from EGFR-mutated lung cancer

Miyuki Abe, Atsushi Osoegawa, Takashi Karashima, Yohei Takumi, Ryoji Kobayashi, Takafumi Hashimoto, Michiyo Miyawaki, Hideya Takeuchi, Tatsuro Okamoto, Kenji Sugio

Metastasis Case report

Re-introducing the same chemotherapy after exposure to anti-PD-1 therapy

Takashi Koyama, Motoo Nomura, Doi Keitaro, Ichiro Tateya, Manabu Muto

Vulvectomy Case report

Adenocarcinoma of intestinal type of the vulva

Tomoko Kurita, Yusuke Matuura, Masanori Hisaoka, Toru Hachisuga

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine